1-2
Editorial
Editorial 3rd Intercontinental Cooperative ITP Study Group (ICIS) Expert Meeting in Basel, Switzerland, September 2009
Thomas Kühne and Paul Imbach
3-4
Basic Science
The working group for “basic science” in ITP at the International Cooperative ITP Study Group (ICIS)
Kenneth J. Clemetson and Simon Panzer
5-10
Management Endpoints
Open AccessConsensus Paper—ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopenia
Hannah Tamary, Jelena Roganovic, Meera Chitlur and Diane J. Nugent
11-17
Review Article
Diagnosis and management of chronic ITP: comments from an ICIS expert group
John David Grainger, Paula H. B. Bolton-Maggs, Bertrand Godeau, Jim Bussel and Hugo Donato, et al.
19-23
Future Research
Future research in ITP: an ICIS consensus
James L. Zehnder, John W. Semple, Paul Imbach, Ellis J. Neufeld and George R. Buchanan, et al.
25-30
Basic Science
The role of Fcγ receptors in murine autoimmune thrombocytopenia
Markus Biburger, Susanne Aschermann, Anja Lux and Falk Nimmerjahn
31-35
Basic Science
Mechanisms of platelet recovery in ITP associated with therapy
Sophie J. Y. Pang and Alan H. Lazarus
37-44
Basic Science
Animal models of immune thrombocytopenia (ITP)
John W. Semple
45-46
Basic Science
Open AccessInvestigating caspases and other markers of apoptosis in ITP
Oliver Speer and Markus Schmugge
47-50
Management Endpoints
Evaluating bleeding severity in immune thrombocytopenia (ITP)
Cindy E. Neunert
51-54
Management Endpoints
Health-related quality of life outcomes for patients with immune thrombocytopenic purpura
Robert J. Klaassen and Nancy L. Young
55-60
Chronic ITP
Treatment of chronic immune thrombocytopenic purpura in adults
Bertrand Godeau and Marc Michel
61-65
Chronic ITP
Chronic immune thrombocytopenic purpura—who needs medication?
Paula H. B. Bolton-Maggs and Victoria S. L. Kok
67-74
Chronic ITP
Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia
Thomas Kühne and Paul Imbach
75-85
Original Article
Open AccessAssessment of immunogenicity of romiplostim in clinical studies with ITP subjects
Vibha Jawa, Martha Hokom, Zheng Hu, Naglaa El-Abaadi and Yao Zhuang, et al.
87-93
Chronic ITP
Moving towards a new era in the management of chronic immune thrombocytopenia
Hans Wadenvik and Bob Olsson
95-103
Future Research
Genetic studies in pediatric ITP: outlook, feasibility, and requirements
Anke K. Bergmann, Rachael F. Grace and Ellis J. Neufeld
105-109
Abstracts
ICIS supplementum abstracts
Thomas Kuehne